Could ‘smart’ GP scripts save a UTI cost blowout?
Australian research shows care for the condition will top $1bn a year unless antimicrobial resistance is tackled
‘Smart’ GP prescribing could help curb a dramatic rise in costs for UTI care to more than $1 billion a year, according to a new Australian report on antimicrobial resistance.
The research by the Outbreak consortium — a multi-institutional initiative to tackle antimicrobial resistance led by the University of Technology Sydney — is the first to comprehensively track the economic cost of antimicrobial resistance in Australia.
